223 related articles for article (PubMed ID: 25813987)
1. Recent advances in the role of cortisol and metabolic syndrome in age-related degenerative diseases.
Martocchia A; Stefanelli M; Falaschi GM; Toussan L; Ferri C; Falaschi P
Aging Clin Exp Res; 2016 Feb; 28(1):17-23. PubMed ID: 25813987
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
[TBL] [Abstract][Full Text] [Related]
3. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
Góth M; Hubina E; Korbonits M
Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
[TBL] [Abstract][Full Text] [Related]
4. The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression.
Dekker MJ; Tiemeier H; Luijendijk HJ; Kuningas M; Hofman A; de Jong FH; Stewart PM; Koper JW; Lamberts SW
J Clin Endocrinol Metab; 2012 Feb; 97(2):E233-7. PubMed ID: 22112815
[TBL] [Abstract][Full Text] [Related]
5. Will treating diabetes with 11β-HSD1 inhibitors affect the HPA axis?
Harno E; White A
Trends Endocrinol Metab; 2010 Oct; 21(10):619-27. PubMed ID: 20594868
[TBL] [Abstract][Full Text] [Related]
6. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
7. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
9. 11β-hydroxysteroid dehydrogenase type 1 inhibitor use in human disease-a systematic review and narrative synthesis.
Gregory S; Hill D; Grey B; Ketelbey W; Miller T; Muniz-Terrera G; Ritchie CW
Metabolism; 2020 Jul; 108():154246. PubMed ID: 32333937
[TBL] [Abstract][Full Text] [Related]
10. 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.
Cooper MS; Stewart PM
J Clin Endocrinol Metab; 2009 Dec; 94(12):4645-54. PubMed ID: 19837912
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
12. Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeys.
Hamilton BS; Schoelch C; Schuler-Metz A; Krosky P; Lala DS; Claremon DA; McGeehan GM
Eur J Pharmacol; 2016 Oct; 789():68-74. PubMed ID: 27393460
[TBL] [Abstract][Full Text] [Related]
13. The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Horm Mol Biol Clin Investig; 2013 Sep; 15(2):37-48. PubMed ID: 25436731
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of Hypothalamo-Pituitary-Adrenocortical Axis in Overweight Female Diabetic Subjects is Associated with Downregulation of Corticosteroid Receptors and 11β-HSD1 in the Brain.
Li S; Liao Y; Wang L; Huang R; Yue J; Xu H; Zhou H; Lou Z; Hu Y; Liu W
Horm Metab Res; 2016 Mar; 48(3):178-84. PubMed ID: 26212138
[TBL] [Abstract][Full Text] [Related]
15. Cortisol on Circadian Rhythm and Its Effect on Cardiovascular System.
Mohd Azmi NAS; Juliana N; Azmani S; Mohd Effendy N; Abu IF; Mohd Fahmi Teng NI; Das S
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33466883
[TBL] [Abstract][Full Text] [Related]
16. The Dehydrogenase Hypothesis.
Woods C; Tomlinson JW
Adv Exp Med Biol; 2015; 872():353-80. PubMed ID: 26216003
[TBL] [Abstract][Full Text] [Related]
17. Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
Anagnostis P; Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
J Clin Endocrinol Metab; 2009 Aug; 94(8):2692-701. PubMed ID: 19470627
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial stress sensitizes neuroendocrine and inflammatory responses to Escherichia coli challenge in domestic piglets.
Tuchscherer M; Puppe B; Tuchscherer A; Kanitz E
Brain Behav Immun; 2018 Feb; 68():274-287. PubMed ID: 29102802
[TBL] [Abstract][Full Text] [Related]
19. HPA axis dysregulation, NR3C1 polymorphisms and glucocorticoid receptor isoforms imbalance in metabolic syndrome.
Martins CS; Elias D; Colli LM; Couri CE; Souza MC; Moreira AC; Foss MC; Elias LL; de Castro M
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27507764
[TBL] [Abstract][Full Text] [Related]
20. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
Walker BR; Andrew R
Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
